VANI

NASD Vivani Medical Inc.
Oct 13, 2026 · 12:51 AM ET EOD Market Closed

$1.19 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.19, $0.04 below the day’s high of $1.23

YTD change
-3.25%
vs 20-day SMA
-3.64%
vs 200-day SMA
-6.12%

Price ranges

Previous day
$1.21 $1.25
open $1.22 close $1.25
+$0.03 (+2.46%)
Today
$1.19 $1.23
open $1.22 now $1.19
-$0.03 (-2.46%)
Past week
$1.19 $1.34
from $1.23 now $1.19
-$0.04 (-3.25%)
Past month
$1.17 $1.34
from $1.27 now $1.19
-$0.08 (-6.30%)
This year
$0.92 $1.66
from $1.23 now $1.19
-$0.04 (-3.25%)

Price & Performance

+0.14 (+13.33%) / 6M

$1.01$1.22$1.43$1.64Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 84.7% away from all-time highs of $7.80
  • VANI is down 3% since the beginning of the year
  • VANI is down 13% over the past 12 months
  • VANI is down 6% over the past 1 month
  • 2% of all VANI investors are betting against VANI

VANI reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -12.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.07
Earnings momentum +16.0% Quarterly EPS growth
Quarterly change +16.0%

Valuation

P/E ratio N/A
Enterprise value $106.9M
Beta 4.15

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$19.9M
Debt$17.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $107.3M

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $762.81 +2.18%
IQV IQVIA Holdings Inc $262.21 +0.90%
CRL Charles River Laboratories International, Inc. $301.86 +0.02%
ICLR ICON Plc $164.40 +0.14%
IT Gartner, Inc. $194.10 +1.54%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.